Hepatitis C virus infection decreases the expression of Toll-like receptors 3 and 7 via upregulation of miR-758

被引:0
|
作者
Qian Yang
Suzhen Fu
Jie Wang
机构
[1] Zhejiang University,State Key Laboratory for Diagnosis and Treatment of Infectious Disease, The First Affiliated Hospital, College of Medicine
来源
Archives of Virology | 2014年 / 159卷
关键词
Plasmid Express Renilla Luciferase; Supersignal WestPico Chemiluminescent Substrate;
D O I
暂无
中图分类号
学科分类号
摘要
Chronic infection with hepatotropic viruses is the main cause of chronic liver disease and cirrhosis worldwide. Toll-like receptor 3 (TLR3) and Toll-like receptor 7 (TLR7) are pathogen-recognition receptors that are expressed on innate immune cells. They recognize viral RNA, which induces their activation, with a subsequent increase in type I interferon transcription. Hepatitis C virus (HCV) infection inhibits the expression of TLR3 and TLR7; however, the mechanism by which this occurs is unclear. MicroRNAs (miRNAs) are small RNAs that posttranscriptionally regulate gene expression. Their aberrant expression is commonly correlated with disease status, as is the case with HCV infection. Here, we found that miR-758 levels were increased in patients with HCV infection and were correlated with TLR3 and TLR7 expression levels in the patients with HCV infection, and bioinformatics analysis predicted that TLR3 and TLR7 are targets of miR-758. Therefore, we postulate that HCV may increase the level of miR-758, which inhibits the expression of TLR3 and TLR7, resulting in a loss of antiviral effect. In order to test our hypothesis, we constructed an HCV core protein expression plasmid and used it to transfect liver cells. The results showed that HCV infection increased miR-758 levels and decreased TLR3/TLR7 expression. Furthermore, using RT-PCR and luciferase reporter analysis, we found that miR-758 targets TLR3 and TLR7, with a subsequent decrease in IFNα and IFNβ production. In conclusion, our results highlight the upregulation of miR-758 expression by HCV as a novel mechanism contributing to downregulation of TLR3 and TLR7 in patients with HCV infection.
引用
收藏
页码:2997 / 3003
页数:6
相关论文
共 50 条
  • [41] The Expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells
    Roelofs, MF
    Joosten, LAB
    Abdollahi-Roodsaz, S
    van Lieshout, AWT
    Sprong, T
    van den Hoogen, FH
    van den Berg, WB
    Radstake, TRDJ
    ARTHRITIS AND RHEUMATISM, 2005, 52 (08): : 2313 - 2322
  • [42] Dysregulation of toll-like receptor (TLR) 2 expression on monocytes and upregulation of the frequency of Tcells expressing TLR2 in patients with chronic hepatitis C virus infection
    Ronit, Andreas
    Salem, Mohammad
    Hartling, Hans J.
    Gaardbo, Julie C.
    Ullum, Henrik
    Gerstoft, Jan
    Nielsen, Susanne D.
    APMIS, 2013, 121 (05) : 437 - 446
  • [43] Expression of Toll-like receptors in the kidney:: their potential role beyond infection
    Schröppel, B
    He, JC
    KIDNEY INTERNATIONAL, 2006, 69 (05) : 785 - 787
  • [44] Defective response to Toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection
    Villacres, M. C.
    Literat, O.
    DeGiacomo, M.
    Du, W.
    Frederick, T.
    Kovacs, A.
    JOURNAL OF VIRAL HEPATITIS, 2008, 15 (02) : 137 - 144
  • [45] Hepatitis C virus inhibits CD4 T cell function via binding to Toll-like receptor 7
    Mele, Dalila
    Mantovani, Stefania
    Oliviero, Barbara
    Grossi, Giulia
    Ludovisi, Serena
    Mondelli, Mario U.
    Varchetta, Stefania
    ANTIVIRAL RESEARCH, 2017, 137 : 108 - 111
  • [46] EXPRESSION LEVEL OF TOLL-LIKE RECEPTORS AND THE PROGNOSIS OF CHRONIC SEVERE HEPATITIS B
    Li, N.
    Chen, M.
    Zhu, M.
    Li, Q.
    Shi, G.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S280 - S280
  • [47] HEPATITIS C VIRUS DIRECTLY ACTIVATES HEPATIC STELLATE CELLS VIA THE TOLL-LIKE RECEPTOR 3 SIGNALING PATHWAY
    Wang, Bo
    Trippler, Martin
    Lu, Mengji
    Broering, Ruth
    Gerken, Guido
    Schlaak, Joerg F.
    HEPATOLOGY, 2009, 50 (04) : 848A - 848A
  • [48] Toll-like receptors are critical for protection against West Nile virus infection
    Sabouri, Amir H.
    Marcondes, Maria Cecilia G.
    Berger, Michael
    Xiao, Nengming
    Beutler, Bruce
    Fox, Howard S.
    Sarvetnick, Nora E.
    FASEB JOURNAL, 2008, 22
  • [49] Toll-like receptors as novel therapeutic targets for herpes simplex virus infection
    Jahanban-Esfahlan, Rana
    Seidi, Khaled
    Majidinia, Maryam
    Karimian, Ansar
    Yousefi, Bahman
    Nabavi, Seyed Mohammad
    Astani, Akram
    Berindan-Neagoe, Ioana
    Gulei, Diana
    Fallarino, Francesca
    Gargaro, Marco
    Manni, Giorgia
    Pirro, Matteo
    Xu, Suowen
    Sadeghi, Mahmoud
    Nabavi, Seyed Fazel
    Shirooie, Samira
    REVIEWS IN MEDICAL VIROLOGY, 2019, 29 (04)
  • [50] The Association of Toll-Like Receptor 4 Polymorphism with Hepatitis C Virus Infection in Saudi Arabian Patients
    Al-Qahtani, Ahmed A.
    Al-Anazi, Mashael R.
    Al-Zoghaibi, Fahad
    Abdo, Ayman A.
    Sanai, Faisal M.
    Khan, Mohammed Q.
    Albenmousa, Ali
    Al-Ashgar, Hamad I.
    Al-Ahdal, Andmohammed N.
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014